Evidence map›Paper›PMID 38022673›Full record

ArticleFrontiers in immunology2023

α-Glucosidase inhibitors boost gut immunity by inducing IgA responses in Peyer's patches.

Kisara Hattori-Muroi, Hanako Naganawa-Asaoka, Yuma Kabumoto, Kei Tsukamoto, Yosuke Fujisaki, Yumiko Fujimura, Seiga Komiyama, Yusuke Kinashi, Miki Kato, Shintaro Sato and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kisara Hattori-MuroiDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Hanako Naganawa-AsaokaDivision of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.
Yuma KabumotoDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Kei TsukamotoDivision of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.
Yosuke FujisakiDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Yumiko FujimuraDivision of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.
Seiga KomiyamaDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Yusuke KinashiDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Miki KatoDivision of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.
Shintaro SatoMucosal Vaccine Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Daisuke TakahashiDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Koji HaseDivision of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Keio University · JPKyoto Biken Laboratories (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peyer's patches (PPs) are specialized gut-associated lymphoid tissues that initiate follicular helper T (Tfh)-mediated immunoglobulin A (IgA) response to luminal antigens derived from commensal symbionts, pathobionts, and dietary sources. IgA-producing B cells migrate from PPs to the small intestinal lamina propria and secrete IgA across the epithelium, modulating the ecological balance of the commensal microbiota and neutralizing pathogenic microorganisms. α-glucosidase inhibitors (α-GIs) are antidiabetic drugs that inhibit carbohydrate digestion in the small intestinal epithelium, leading to alterations in the commensal microbiota composition and metabolic activity. The commensal microbiota and IgA responses exhibit bidirectional interactions that modulate intestinal homeostasis and immunity. However, the effect of α-GIs on the intestinal IgA response remains unclear. We investigated whether α-GIs affect IgA responses by administering voglibose and acarbose to mice via drinking water. We analyzed Tfh cells, germinal center (GC) B cells, and IgA-producing B cells in PPs by flow cytometry. We also assessed pathogen-specific IgA responses. We discovered that voglibose and acarbose induced Tfh cells, GCB cells, and IgA-producing B cells in the PPs of the proximal small intestine in mice. This effect was attributed to the modification of the microbiota rather than a shortage of monosaccharides. Furthermore, voglibose enhanced secretory IgA (S-IgA) production against attenuated

Indexed as

Glycoside Hydrolase InhibitorsImmunoglobulin AAcarboseAnimalsAntigensInositolMicePeyer's PatchesAcarboseAntigensGlycoside Hydrolase InhibitorsImmunoglobulin AInositolvoglibosefollicular helper T cellimmunoglobulin Apeyer’s patchvogliboseα-glucosidase inhibitor

Identifiers

PMID38022673
PMCPMC10646501
OpenAlexW4388183217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.